These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17006401)

  • 21. Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women.
    Saxena BN; Dusitsin N; Tankeyoon M; Chaudhury RR
    J Med Assoc Thai; 1980 Feb; 63(2):66-9. PubMed ID: 7365344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.
    Narvekar N; Glasier A; Dada K; Van der Spuy Z; Ho PC; Cheng L; Baird DT
    Fertil Steril; 2006 Oct; 86(4):819-24. PubMed ID: 17027354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable hormones and regulatory controversy: an end to the long-running story?
    Klitsch M
    Fam Plann Perspect; 1993; 25(1):37-40. PubMed ID: 8432375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.
    Morroni C; Grams M; Tiezzi L; Westhoff C
    Contraception; 2004 Jul; 70(1):19-23. PubMed ID: 15208048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial.
    Cheewadhanaraks S; Choksuchat C; Dhanaworavibul K; Liabsuetrakul T
    Gynecol Obstet Invest; 2012; 74(2):151-6. PubMed ID: 22722530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study.
    Thurman AR; Soper DE
    Infect Dis Obstet Gynecol; 2006; 2006():69402. PubMed ID: 17093355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of pretreatment counseling on discontinuation rates in women given depo-medroxyprogesterone acetate for contraception].
    Lei Z; Wu S; Garceau RJ
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):350-3. PubMed ID: 9596915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing changes in vaginal bleeding patterns in contracepting women.
    Machin D; Farley TM; Busca B; Campbell MJ; d'Arcangues C
    Contraception; 1988 Aug; 38(2):165-79. PubMed ID: 2971504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density in adolescent females using depot medroxyprogesterone acetate.
    Lara-Torre E; Edwards CP; Perlman S; Hertweck SP
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):17-21. PubMed ID: 15010034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depo Now: preventing unintended pregnancies among adolescents and young adults.
    Rickert VI; Tiezzi L; Lipshutz J; León J; Vaughan RD; Westhoff C
    J Adolesc Health; 2007 Jan; 40(1):22-8. PubMed ID: 17185202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.
    Gardner JM; Mishell DR
    Fertil Steril; 1970 Apr; 21(4):286-91. PubMed ID: 5508497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol.
    Goldberg AB; Cardenas LH; Hubbard AE; Darney PD
    Contraception; 2002 Oct; 66(4):215-20. PubMed ID: 12413614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injectable contraceptives.
    Toppozada M
    Contracept Deliv Syst; 1982 Apr; 3(2):161-70. PubMed ID: 12338171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.
    Tantiwattanakul P; Taneepanichskul S
    Contraception; 2004 Oct; 70(4):277-9. PubMed ID: 15451330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA.
    Hussein M
    Arch Gynecol Obstet; 2011 Jun; 283(6):1325-8. PubMed ID: 20582427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.